Adverse Events Associated With Coprescription of Phosphodiesterase Type 5 Inhibitors and Oral Organic Nitrates in Male Patients With Ischemic Heart Disease
Authors:
- Anders HoltAHAnders Holt
- Paul BlanchePBPaul Blanche
- Aksel Karl Georg JensenAJAksel Karl Georg Jensen
- Deepthi RajanDRDeepthi Rajan
- Mads Hashiba JensenMJMads Hashiba Jensen
- Mohammed El-SheikhMEMohammed El-Sheikh
- Gunnar GislasonGGGunnar Gislason
- Christian Torp-PedersenCTChristian Torp-Pedersen
- Patricia McGettiganPMPatricia McGettigan
- 1 June 2022
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 175 (6) , 774-782
Abstract
Using oral nitrates and phosphodiesterase type 5 inhibitors together can lead to abnormally low blood pressure, which in turn could cause harms such as syncope, stroke, and acute myocardial infarct... Visual Coprescription of Oral Organic Nitrates and PDE5 Inhibitors. Using oral nitrates and phosphodiesterase type 5 inhibitors together can lead to abnormally low blood pressure, which in... Background: Concomitant use of oral organic nitrates (nitrates) and phosphodiesterase type 5 (PDE5) inhibitors is contraindicated. Objective: To measure temporal trends in the coprescription of nit...Keywords
Funding Information
- Dagmar Marshalls Fond
- Snedkermester Sophus Jacobsen og Hustru Astrid Jacobsens Fond (J 167/1)
- Marie og M.B. Richters Fond (2020-0379)
- Ib Mogens Kristiansens Almene Fond (30206-383)
- Helsefonden (20-B-0035)
This publication has 28 references indexed in Scilit:
- A Systematic Review of the Association Between Erectile Dysfunction and Cardiovascular DiseaseEuropean Urology, 2014
- Sexual Activity and Cardiovascular DiseaseCirculation, 2012
- The Danish National Prescription RegistryScandinavian Journal of Public Health, 2011
- Drug Interactions With Phosphodiesterase-5 Inhibitors Used for the Treatment of Erectile Dysfunction or Pulmonary HypertensionCirculation, 2010
- Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risksInternational Journal Of Clinical Practice, 2010
- Time‐dependent interactions of the hypotensive effects of sildenafil citrate and sublingual glyceryl trinitrateBritish Journal of Clinical Pharmacology, 2009
- Safety of intravenous nitroglycerin after administration of sildenafil citrate to men with coronary artery disease: A double-blind, placebo-controlled, randomized, crossover trial*Critical Care Medicine, 2007
- Tutorial in biostatistics: competing risks and multi‐state modelsStatistics in Medicine, 2006
- Association between Cellular-Telephone Calls and Motor Vehicle CollisionsNew England Journal of Medicine, 1997
- THE CASE-TIME-CONTROL DESIGNEpidemiology, 1995